and Memory Disorders Center
The Alzheimer's Disease and Memory Disorders Center at Baylor College of Medicine was established in 1989 and is headed by Rachelle S. Doody, M.D., Ph.D., the Effie Marie Cain Chair in Alzheimer's Disease Research. The center is one of only a few in the country dedicated to both patient care and research.
Our focus is on the translation of discoveries made in the laboratory into improved methods of disease prevention, diagnosis, and treatment. We participate in the design or supervision of many Alzheimer's disease or memory disorders trials taking place in the world, and are recognized nationally and internationally for our contributions to the diagnosis and treatment of Alzheimer's disease.
The ADMDC was involved in the development of all five of the commercially available, FDA-approved drugs for Alzheimer's disease, and was the lead site for the development of the most widely prescribed Alzheimer's disease drug worldwide. In addition to developing treatments for Alzheimer's disease, one focus of the center is on research trials testing interventions to prevent Alzheimer's disease in normal subjects, as well as in individuals who are at greater risk for developing the disease.
The center is also part of a national effort to use neuroimaging techniques to develop diagnostic tests to identify or predict Alzheimer's disease, even in persons who do not yet show symptoms of disease.
Because we adopt a longitudinal approach to patient care, we are able to gather and analyze information about our patients for many years. We are using this information to create predictive models of disease progression, so that we can someday advise patients and their families in advance of what to expect over the course of their illness. We will also use this information to design clinical trials for new agents designed to slow the progression of Alzheimer's disease.
Each year, the ADMDC manages more than 3,000 patient visits. People come to the center for diagnosis of their memory problems, treatment and disease management, and to participate in research studies. The ADMDC approach to patient care is comprehensive and addresses the needs of both the patient and the family.
Following diagnosis, patients and their family members are seen regularly to ensure continuous monitoring and treatment of disease progression, and to discuss the most recent developments in therapeutics and research. The ADMDC has a full time clinical psychologist who provides counseling, support, education, and referral services for each patient and family at the time of their initial visit, at all yearly checkups, and on an as needed basis in between.
We seek to improve the care of those with Alzheimer's disease and other memory disorders by educating physicians and health services providers locally, nationally, and globally. By heading a collaborative, multi-institutional team of clinical and academic researchers from the University of Texas Health Sciences Center, the Houston VA Medical Center, Quentin Meece Hospital, and the University of Houston, the ADMDC advances the broader understanding of Alzheimer's disease through scholarly publications and contributions to medical, clinical, and academic journals.
Locally, the ADMDC is dedicated to providing members of the Houston community and surrounding areas with evidence-based diagnostic and clinical care, as well as opportunities to participate in clinical trials for promising therapies. Nationally and internationally, we contribute to research designed to learn the causes of Alzheimer's disease, and to develop new prevention and treatment strategies.
Alzheimer's Disease and Memory Disorders Center
Department of Neurology
Baylor College of Medicine
The Medical Building
1977 Butler Blvd., Suite E5.101
Houston, Texas 77030